Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TIL
INSTIL BIO, INC.
NASDAQ
$7.58
▼ DOWN 3.56% (-0.28)

KEY STATISTICS

Market Cap$51.41 M
52w High$33.83
52w Low$5.67
Dividend Yield—
Frequency—
P/E-1.70
Volume14.28K
Shares Out.6.78M

COMPANY

LEADERSHIP

Bronson Crouch
CHIEF EXECUTIVE
Bronson Crouch

COMPENSATION 2026

Salary$740,520
Stock Awards$0
Incentive Plan Pay$421,171
All Other Comp.$15,200
Total$2,256,412

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 19, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
17

PRICE TARGET

Target High$120.00
Target Low$2.00
Target Median$9.00
Target Consensus$35.00

UPCOMING EARNINGS

DateNov 16, 2026
DayMonday
Rev. Est.—
NOV
16
MON

SPLIT RECORD

DATETYPERATIO
2023-12-08Reverse1:20

PRICE

$7.58 ▼ DOWN 3.56% (−$0.28)
OVERLAYS
$7.50$7.60$7.709:32 AM10:37 AM11:41 AM12:45 PM1:50 PM2:55 PM3:59 PM7.58

About Instil Bio, Inc.

https://instilbio.com ↗

Instil Bio, Inc. is a Dallas-based clinical-stage biopharmaceutical company developing autologous TIL cell therapies for various cancers, including melanoma, lung, and gynecological cancers.

INDUSTRY

Biotechnology

A SERVICE INSTIL BIO, INC. IS KNOWN FOR

Strategic In-licensing and Business Development

Following the discontinuation of key clinical candidates, Instil Bio is now focused on identifying, acquiring, or licensing new therapeutic assets to rebuild its product pipeline.

COMPETITORS

COMPETITOR
ALLO COMPARE
FATE COMPARE
IOVA COMPARE
TCRX COMPARE

Revenue by Geography

MapREGIONQ1-2017Q2-2017Q3-2017Q4-2017
CANADA$349.4K $675.84K ▲$483K ▼—
BERMUDA$434.47K $416.85K ▼— $39.58K ▼
UNITED STATES$639.55K $46.6K ▼— -$102.2K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
17
LISTED HERE
5
RANKED BY POSITION SIZE
VTS.AX
0.00% · 119.0K
CN
CNCR
3.59% · 93.2K
IWC
0.01% · 13.0K
AVSC
0.00% · 7.5K
DFAS
0.00% · 6.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
61.95%
HOLDERS
52
TOP 12 OF 52 · RANKED BY POSITION SIZE
Marshall Wace North America L.P.
1.4M sh · $25.85M
Bml Capital Management, LLC
645.6K sh · $5.32M
Cpmg Inc
410.9K sh · $3.39M
Boxer Capital, LLC
355.5K sh · $23.93M
Vivo Capital, LLC
292.7K sh · $2.41M
Millennium Management LLC
242.8K sh · $2.67M
Siren, L.L.C.
203.9K sh · $2.24M
Vanguard Group Inc
191.1K sh · $2.1M
Sectoral Asset Management Inc
161.4K sh · $2.88M
Morgan Stanley
102.9K sh · $1.84M
Dimensional Fund Advisors LP
80.8K sh · $1.44M
Renaissance Technologies LLC
67.8K sh · $745.8K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
DIRECTOR
McGaughy R Kent Jr
Purchase · 6.5K shares
2026-06-11
★
DIRECTOR
Matcham George
Purchase · 6.5K shares
2026-06-11
★
DIRECTOR
Gibson Neil W
Purchase · —
2026-06-11
★
DIRECTOR
Binder Gwendolyn
Purchase · 6.5K shares
2026-06-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 3
3 GRADES IN THE LAST 12 MONTHS
H.C. Wainwright NEUTRAL HC Wainwright & Co. NEUTRAL Baird NEUTRAL

SECTORS PEERS

PEERPRICE
STTK$7.04COMPARE
IFRX$2.23COMPARE
ZNTL$3.80COMPARE
WHWK$4.62COMPARE
MGNX$4.13COMPARE
SRZN$22.42COMPARE
ONCY$0.86COMPARE
PLRX$1.11COMPARE